Background
Some infants with perinatally-acquired HIV who begin antiretroviral therapy (ART) early in life may test HIV antibody negative in early childhood. We examine whether this is a persisting phenomenon, and factors influencing antibody profile during ART.
Methods
HIV-1 Western Blot (WB) assays were conducted on blood samples from 215 children living with HIV (CLWH) and 57 age-matched children without HIV (controls) at exit from an observational study undertaken at two sites in South Africa. Associations between viral load (VL), CD4 counts, HIV-1 DNA PCR past VL results, age at ART start, pre-ART characteristics and WB result (coded as negative, indeterminate, or positive) and reactivity to specific proteins (coded as negative, equivocal, weak positive, or strong positive) were tested using chi-square.
Results
In CLWH median age was 10 years (IQR 8.7-11.0), ART was started at 153 days (IQR 99-228), 75% had undetectable VL and 53% were female. Controls were 9.1 years (IQR 8.0-9.8) and 44% were female. In CLWH, 11 (5%) had negative WB, and 67 (31%) were indeterminate. Negative/equivocal reactivity to p18 occurred in 82%, p24 20%, p31 70%, p40 33%, p51 39%, p55 39%, p65 67%, gp41 70%, gp120 78% and gp160 29%. In controls, 44 (77%) were WB negative and none were positive. In controls, equivocal or weak reactivity was observed for p18 in 11%, p24 4%, p31 5%, p40 0%, p51 4%, p55 4%, p65 2%, gp41 2%, gp120 0%, and gp160 0%. WB findings did not differ by sex. In CLWH, negative or indeterminate WB was associated with: concurrent undetectable VL; a history of always being undetectable; concurrent negative HIV-1 DNA PCR or in the top quintile of cycle threshold (CT) values (lowest HIV DNA). In CLWH with undetectable VL, a consistent history of being undetectable was significantly associated with negative/equivocal reactivity across all the proteins in the WB (Figure). In contrast, younger age at ART start was significantly associated with greater likelihood of negative/equivocal results only to gp160 (Figure). Likewise, low HIV DNA was associated with greater likelihood of negative/equivocal results only to p65 and gp160.
Conclusions
Almost a decade after ART was started in infancy, those who initiated treatment in the first few months of life have less reactivity to gp160. Using an indirect marker, negative and indeterminate WB are associated with lower levels of total HIV-1 DNA. WB assays are a sensitive means to track past history of viral control on ART.
Table or Figure
